CL2014001518A1 - Composicion de lagrima artificial porque es una emulsion sin sales que comprende aceite de ricino y un agente seleccionado de polisorbato, carboximetilcelulosa y glicerina, excluyendo aceite de oliva.; una emulsion; y un metodo para aliviar los ojos secos. - Google Patents

Composicion de lagrima artificial porque es una emulsion sin sales que comprende aceite de ricino y un agente seleccionado de polisorbato, carboximetilcelulosa y glicerina, excluyendo aceite de oliva.; una emulsion; y un metodo para aliviar los ojos secos.

Info

Publication number
CL2014001518A1
CL2014001518A1 CL2014001518A CL2014001518A CL2014001518A1 CL 2014001518 A1 CL2014001518 A1 CL 2014001518A1 CL 2014001518 A CL2014001518 A CL 2014001518A CL 2014001518 A CL2014001518 A CL 2014001518A CL 2014001518 A1 CL2014001518 A1 CL 2014001518A1
Authority
CL
Chile
Prior art keywords
emulsion
polysorbate
glycerin
salts
composition
Prior art date
Application number
CL2014001518A
Other languages
English (en)
Inventor
Joseph G Vehige
Peter A Simmons
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47459152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2014001518(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of CL2014001518A1 publication Critical patent/CL2014001518A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CL2014001518A 2011-12-07 2014-06-09 Composicion de lagrima artificial porque es una emulsion sin sales que comprende aceite de ricino y un agente seleccionado de polisorbato, carboximetilcelulosa y glicerina, excluyendo aceite de oliva.; una emulsion; y un metodo para aliviar los ojos secos. CL2014001518A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161568089P 2011-12-07 2011-12-07
US201261625401P 2012-04-17 2012-04-17

Publications (1)

Publication Number Publication Date
CL2014001518A1 true CL2014001518A1 (es) 2014-10-24

Family

ID=47459152

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014001518A CL2014001518A1 (es) 2011-12-07 2014-06-09 Composicion de lagrima artificial porque es una emulsion sin sales que comprende aceite de ricino y un agente seleccionado de polisorbato, carboximetilcelulosa y glicerina, excluyendo aceite de oliva.; una emulsion; y un metodo para aliviar los ojos secos.

Country Status (28)

Country Link
US (2) US9314528B2 (es)
EP (4) EP2787969B1 (es)
JP (1) JP6142419B2 (es)
KR (1) KR102017922B1 (es)
CN (2) CN104114152A (es)
AR (1) AR089123A1 (es)
AU (2) AU2012347459A1 (es)
BR (1) BR112014013820A2 (es)
CA (1) CA2858574C (es)
CL (1) CL2014001518A1 (es)
CO (1) CO6990739A2 (es)
DK (2) DK2787969T3 (es)
ES (2) ES2896336T3 (es)
HK (2) HK1201458A1 (es)
HU (2) HUE049489T2 (es)
IL (1) IL233008A (es)
IN (1) IN2014CN04809A (es)
MX (1) MX355216B (es)
MY (1) MY173378A (es)
PH (1) PH12014501296A1 (es)
PL (2) PL2787969T3 (es)
PT (2) PT2787968T (es)
RU (1) RU2014127074A (es)
SG (1) SG11201403013VA (es)
SI (2) SI2787969T1 (es)
TW (1) TWI652072B (es)
WO (2) WO2013086449A1 (es)
ZA (1) ZA201404228B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8957048B2 (en) * 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
RS58292B1 (sr) 2016-07-07 2019-03-29 Salvat Lab Sa Oftalmološka kompozicija sa ricinusovim uljem i srednjim lancem triglicerida
CA3032695C (en) 2016-08-19 2021-11-23 Akrivista, LLC Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye
CN114376961A (zh) 2017-08-18 2022-04-22 阿克里维斯塔有限责任公司 诊断和治疗干眼综合症的方法和用于治疗人类眼睛的组合物
US11096958B2 (en) 2018-04-27 2021-08-24 Allergan, Inc. Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced toxicity

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201706A (en) 1978-09-22 1980-05-06 Burton, Parsons & Company, Inc. Treatment of corneal edema
DE3066859D1 (en) 1979-10-26 1984-04-12 Smith & Nephew Ass Autoclavable emulsions
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
IT1224795B (it) 1988-12-01 1990-10-24 Sigma Tau Ind Farmaceuti Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
DE436726T1 (de) 1989-08-03 1992-02-06 Eisai Co., Ltd., Tokio/Tokyo, Jp Verfahren zur photostabilisierung von augenspuelloesungen sowie photostabilisierte augenspuelloesung.
US5681555A (en) 1991-04-22 1997-10-28 Gleich; Gerald J. Method for the treatment of bronchial asthma by parenteral administration of anionic polymers
DE4229494A1 (de) 1992-09-04 1994-03-10 Basotherm Gmbh Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks
EP0778021A4 (en) 1994-09-14 1998-06-03 Taisho Pharmaceutical Co Ltd DROPS TO CARE FOR THE CORNEA
US5980865A (en) 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
FI106923B (fi) 1997-01-03 2001-05-15 Cultor Ltd Finnsugar Bioproduc Trimetyyliglysiinin käyttö kehon limakalvojen hygieniaan ja hoitoon tarkoitetuissa valmisteissa
AR002194A1 (es) 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.
IT1302307B1 (it) 1998-09-01 2000-09-05 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
AU1295200A (en) 1998-11-13 2000-06-05 Continental Projects Limited Complexes of hyaluronic acid/carnitines and pharmaceutical and cosmetic compositions
JP2000159659A (ja) * 1998-11-30 2000-06-13 Kazuo Tsubota 眼科用人工涙液
US6228392B1 (en) 1999-04-29 2001-05-08 Gene Tools, Llc Osmotic delivery composition, solution, and method
BR0112461A (pt) 2000-07-14 2003-07-22 Allergan Inc Composições que contém componentes terapeuticamente ativos tendo uma solubilidade aumentada
CA2355814C (en) 2000-09-14 2010-06-29 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Pharmaceutical composition for ophthalmic use
DK1339418T3 (da) 2000-11-08 2009-12-14 Fxs Ventures Llc Forbedret ophthalmiske og kontaktlinseoplösninger indeholdende simple saccharider som konserverende forstærkere
US7045121B2 (en) 2001-12-14 2006-05-16 Allergan, Inc. Ophthalmic compositions for lubricating eyes and methods for making and using same
WO2004028536A1 (en) 2002-09-30 2004-04-08 Babizhayev Mark A Method for topical treatment of eye disease and composition and device for said treatment
AU2003301263A1 (en) * 2002-10-18 2004-05-04 Joel S. Echols Three layer tear formulation
US20040137079A1 (en) 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
US6635654B1 (en) * 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine
WO2004084877A1 (ja) 2003-03-26 2004-10-07 Menicon Co., Ltd. 眼科用組成物
JP4860475B2 (ja) * 2003-06-13 2012-01-25 アルコン，インコーポレイテッド ２種のポリマーの相乗作用的組み合わせを含む眼科用組成物
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
US20050009836A1 (en) 2003-06-26 2005-01-13 Laskar Paul A. Ophthalmic composition containing quinolones and method of use
EP1683528A4 (en) * 2003-11-10 2011-07-27 Toray Industries POLYSACCHARIDE-CONTAINING COMPOSITION AND OPHTHALMIC SOLUTION FOR STABILIZING THE TISSUE FILM
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
US7288520B2 (en) * 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US9561178B2 (en) * 2006-07-25 2017-02-07 Allergan, Inc. Cyclosporin compositions
WO2008035246A2 (en) * 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
CN101896160A (zh) * 2006-10-17 2010-11-24 阿勒根公司 环胞菌素组合物
CA2679448A1 (en) * 2007-02-28 2008-09-04 Aciex, Inc. Methods and compositions for normalizing meibomian gland secretions
JP4929245B2 (ja) 2008-07-31 2012-05-09 株式会社ベッセル工業 工具類のグリップ
NZ596932A (en) 2009-06-05 2014-04-30 Allergan Inc Artificial tears and therapeutic uses
US8957048B2 (en) * 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye

Also Published As

Publication number Publication date
AU2017265181A1 (en) 2017-12-14
IN2014CN04809A (es) 2015-09-18
EP3981387A1 (en) 2022-04-13
RU2018119362A3 (es) 2021-09-07
ZA201404228B (en) 2015-12-23
KR102017922B1 (ko) 2019-09-03
IL233008A0 (en) 2014-07-31
BR112014013820A8 (pt) 2017-06-13
TWI652072B (zh) 2019-03-01
EP2787969B1 (en) 2021-09-29
PH12014501296A1 (en) 2014-10-08
PT2787969T (pt) 2021-11-09
CA2858574A1 (en) 2013-06-13
CA2858574C (en) 2017-05-30
WO2013086438A1 (en) 2013-06-13
KR20140107383A (ko) 2014-09-04
DK2787968T3 (da) 2020-06-02
MY173378A (en) 2020-01-21
EP2787969A1 (en) 2014-10-15
PL2787969T3 (pl) 2021-12-20
US20130197083A1 (en) 2013-08-01
AU2017265181B2 (en) 2019-06-20
RU2018119362A (ru) 2018-11-08
MX355216B (es) 2018-04-10
US9314528B2 (en) 2016-04-19
JP2015504860A (ja) 2015-02-16
BR112014013820A2 (pt) 2017-06-13
EP2787968A1 (en) 2014-10-15
ES2896336T3 (es) 2022-02-24
HK1201458A1 (en) 2015-09-04
DK2787969T3 (da) 2021-11-01
HK1203057A1 (en) 2015-10-16
CO6990739A2 (es) 2014-07-10
AR089123A1 (es) 2014-07-30
EP3666257A1 (en) 2020-06-17
CN104114152A (zh) 2014-10-22
WO2013086449A1 (en) 2013-06-13
MX2014006804A (es) 2014-09-22
JP6142419B2 (ja) 2017-06-07
PT2787968T (pt) 2020-06-16
IL233008A (en) 2017-07-31
US20130150324A1 (en) 2013-06-13
TW201325633A (zh) 2013-07-01
EP2787968B1 (en) 2020-03-04
RU2014127074A (ru) 2016-02-10
HUE049489T2 (hu) 2020-09-28
CN108969482A (zh) 2018-12-11
SI2787969T1 (sl) 2021-12-31
HUE057140T2 (hu) 2022-04-28
SG11201403013VA (en) 2014-07-30
ES2797650T3 (es) 2020-12-03
SI2787968T1 (sl) 2020-08-31
PL2787968T3 (pl) 2020-08-24
AU2012347459A1 (en) 2014-07-03

Similar Documents

Publication Publication Date Title
CL2014001518A1 (es) Composicion de lagrima artificial porque es una emulsion sin sales que comprende aceite de ricino y un agente seleccionado de polisorbato, carboximetilcelulosa y glicerina, excluyendo aceite de oliva.; una emulsion; y un metodo para aliviar los ojos secos.
CL2013002134A1 (es) Composicion farmaceutica oftalmica de administracion topica que comprende un androgeno; y metodo para tratar una afeccion ocular resultante de una deficiencia de androgeno.
CL2014002858A1 (es) Articulo para fumar que comprende una varilla de material fumable y un filtro unido a un extremo de la varilla, el filtro comprende dos secciones y envuelto en una envoltura de tapón porosa, la envoltura se superpone a la unión entre la varilla y el filtro, una envoltura de boquilla adicional se proporciona al filtro la cual es menos porosa.
CL2014003619A1 (es) Jeringa prellenada que comprende una solución de un antagonista de vegf; empaque blister; uso de la jeringa para tratar enfermedades oculares.
CL2013002612A1 (es) Compuestos derivados de c4-monometil triterpenoides; composicion farmaceutica que los comprende; y metodo para tratar o prevenir una enfermedad o un trastorno.
CL2014003121A1 (es) Formulacion liquida que comprende propilenglicol y un inodilatador, un inhibidor de la enzima convertidora de angiotensina o una combinacion de ambos; proceso para prepararla; kit; y metodo de tratamiento de una enfermedad cardiaca y/o hipertension.
CL2014002674A1 (es) Compósicion inmunogenica que comprende una porcion soluble de una preparacion de celulas enteras de mycoplasma hyopneumoniae (m. hyo); procedimiento para inmunizar; procedimiento de preparacion.
CO6960545A2 (es) Un medicamento para tratar la enfermedad del ojo anterior que comprende rebamipida y un agente de retención de lágrimas
MX2016006896A (es) Microcapsulas de lipidos que comprenden preferiblemente una substancia activa lipofilica y composicion que las contiene, su metodo de preparacion y su uso en dermatolgia y cosmetica.
CL2013000734A1 (es) Uso de una composicion que comprende compuestos derivados de 1-h-imidazol-4-il sustituido para bajar la presion intraocular; kit farmaceutico.
CL2015000434A1 (es) Metodo para el tratamiento, prevencion o disminucion de la severidad de una condicion o trastorno no neoplasico de la piel que comprende administrar un compuesto derivado de retinoides; composicion dermica que comprende los derivados de retinoide.
CL2013000237A1 (es) Composicion farmaceutica que comprende un sirna dirigido a vegfa; y metodo para disminuir la expresion de vegfa in vivo.
CL2013001579A1 (es) Uso de una composicion farmaceutica que comprende un compuesto agonista ep4 para tratar marcas de la piel tales como heridas superficiales, cicatrices o arrugas.
BR112014029885A8 (pt) Composições tópicas, que contêm um retinoide, de tipo emulsão óleo em água
BR112015012149A2 (pt) método para a remoção de uma ou mais substâncias químicas de um material de tabaco, material de tabaco, artigo para fumar e uso de um líquido iônico para remover proteínas e/ou polifenóis
CR20120456A (es) Un concentrado preformado para entrega de polimeros que forman una pelicula insoluble en agua
BR112015003693A2 (pt) composição líquida aquosa para limpar a pele, produto embalado e método de limpeza e remoção de maquiagem.
CL2012001835A1 (es) Uso de una formulacion que comprende un agente viscogenico y moxifloxacina para preparar un medicamento util para tratar el oido medio.
CL2014002831A1 (es) Composiciones parasiticidas que comprenden derivados de benzimidazol, métodos y usos de los mismos para tratar infestacion por helmintos.
MX353744B (es) Mezcla humectante mejorada.
CL2014000509A1 (es) Co-cristales que comprenden ciprodinil y ditianon; proceso para preparar los co-cristales; composicion para la proteccion de cultivos que comprende dichos co-cristales; uso para combatir hobgos fitopatógenos.
BR112014016738A2 (pt) composição cosméstica aquosa que compreende alquilecelulode, óleos não voláteis , pelo menos uma cera e pelo menos um tensoativo geminado
BR112014015542A8 (pt) composição de óleo para os cabelos, método para nutrir os cabelos e dispensador
FR2991175B1 (fr) Compositions pharmaceutiques topiques de type emulsion h/e contenant un retinoide
CL2015000062A1 (es) Generación electroquímica de derivados de urea clorada; metodo para tratar un liquido; y metodo de generacion de n-n´-dimetilurea clorada.